AstraZeneca strikes £309 million deal with Japan’s Takeda Pharmaceutical



ASTRAZENECA has struck a deal worth up to $400 million with Japan’s Takeda Pharmaceutical to co-develop and commercialise a potential treatment for Parkinson’s disease. »
AstraZeneca strikes £309 million deal with Japan’s Takeda Pharmaceutical AstraZeneca strikes £309 million deal with Japan’s Takeda Pharmaceutical Reviewed by Unknown on 30 August Rating: 5

No comments:

Trending News

Powered by Blogger.